Brian S Brown

This inventor holds 21 USPTO granted patents and 11 published patent applications and 7 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Abbott Laboratories Corporation, Abbvie Inc., Abbvie S.a.r.l.. Active years: 2006-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian S Brown. Retrieved from https://idiyas.com/inventor/brian-s-brown

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 11)

% Patents Active = 52.4

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 48(Granted Patents)

Company Filing History:

10 out of 4,190

Abbott Laboratories Corporation

Calico Life Sciences LLC

patents

where one patent can have more than one assignee

Years Active: 2006-2021

Loading Chart...

Areas of Expertise:

Prodrug Modulators

Potassium Channel Modulators

TRPV1 Antagonists

Cystic Fibrosis Compounds

Anti-Viral Compounds

Amide Derivatives

Chromanylurea Compounds

Vanilloid Receptor

Stress Pathway Modulation

Pain Treatment

N-Sulfonylated Compounds

Tetrahydroquinolinyl Compounds

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11149043 - Prodrug modulators of the integrated stress pathway (2021-10-19),

2. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2020-05-12),

3. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2019-04-16),

4. 10130622 - Compounds for treatment of cystic fibrosis (2018-11-20),

5. 10053474 - Anti-viral compounds (2018-08-21),

6. 9890158 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2018-02-13),

7. 8859549 - Potassium channel modulators (2014-10-14),

8. 8815930 - Compounds that inhibit TRPV1 and uses thereof (2014-08-26),

9. 8629143 - Potassium channel modulators (2014-01-14),

10. 8598220 - Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof (2013-12-03),

11. 8440691 - Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof (2013-05-14),

12. 8232309 - Prodrugs of compounds that inhibit TRPV1 receptor (2012-07-31),

13. 7998982 - Amide derivatives as TRPV1 antagonists (2011-08-16),

14. 7812019 - Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof (2010-10-12),

15. 7767705 - Compounds that inhibit TRPV1 and uses thereof (2010-08-03),

Title: Innovations by Brian S Brown in Evanston, IL

Introduction

Brian S Brown is a prolific inventor based in Evanston, Illinois, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 21 patents, his work has had a substantial impact on the development of therapies aimed at treating complex medical conditions.

Latest Patents

Among his latest innovations, Brown has developed formulations such as Prodrug modulators of the integrated stress pathway. This invention provides compounds, compositions, and methods that are essential for modulating the integrated stress response (ISR) and treating associated diseases and disorders. Another noteworthy patent is for N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides, which includes methods to utilize these compounds in treating conditions mediated by CFTR, such as cystic fibrosis, Sjögren's syndrome, and chronic obstructive pulmonary diseases.

Career Highlights

Throughout his career, Brian S Brown has worked with leading organizations in the pharmaceutical industry, notably Abbott Laboratories and AbbVie Inc. His experience in these companies has provided him with a strong foundation in drug development and innovation.

Collaborations

Brian has collaborated with distinguished colleagues, including Chih-hung Lee and John R Koenig, enhancing the quality and breadth of his research and patent submissions. Their combined efforts have significantly advanced the development of innovative therapies.

Conclusion

As an inventor with a track record of impactful innovations, Brian S Brown continues to contribute to the medical field through his patents. His work demonstrates the importance of scientific research in creating new treatments that address critical health challenges.

Profile summary based on public USPTO records.